These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37872211)

  • 1. RNA modification regulator DDC in endometrial cancer affects the tumor microenvironment and patient prognosis.
    Zhao H; Shi C; Zhao G; Liu J; Wang X; Liang J; Li F
    Sci Rep; 2023 Oct; 13(1):18057. PubMed ID: 37872211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Analysis of Tumor Microenvironment Patterns and Oxidative Stress Characteristics of Endometrial Carcinoma Mediated by 5-Methylcytosine Regulators.
    Dong C; Dang L; Gao X; Xu R; Zhang H; Zhang X
    Oxid Med Cell Longev; 2022; 2022():6431164. PubMed ID: 36187339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
    Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
    Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of prediction model for prognosis of uterine corpus endometrial carcinoma based on pyroptosis gene.
    Zhang C; Bai J; Yang Y; Wang X; Liu W; Hou S; Ai Z; Xia Q; Shao L
    Clin Transl Oncol; 2023 May; 25(5):1413-1424. PubMed ID: 36520385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Fang F; Wang P; Huang H; Ye M; Liu X; Li Q
    BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma.
    Wang Z; Xing L; Huang Y; Han P
    Cancer Med; 2023 Feb; 12(3):3797-3811. PubMed ID: 36812126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.
    Chen R; Sun K; Hou Y; Shen J; Chen J; Dong F; Wang X; Yang L; Zhang L
    Biomed Res Int; 2022; 2022():8776678. PubMed ID: 36467881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel risk prediction model of pyroptosis-related genes for the prognosis and immunotherapy response of endometrial cancer.
    Liu ZS; Jing CL
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2259-2278. PubMed ID: 35442481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma.
    Wu Q; Tian R; Liu J; Ou C; Li Y; Fu X
    Front Immunol; 2023; 14():1139126. PubMed ID: 36936912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma.
    Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR
    Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
    Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
    J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma.
    Song S; Gu H; Li J; Yang P; Qi X; Liu J; Zhou J; Li Y; Shu P
    Sci Rep; 2023 Jun; 13(1):9255. PubMed ID: 37286702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01589 serves as a potential tumor-suppressor and immune-related biomarker in endometrial cancer: A review.
    Chen R; An J; Wang Y; Yang L; Lin Q; Wang Y
    Medicine (Baltimore); 2023 Apr; 102(15):e33536. PubMed ID: 37058060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HOX family regulator-mediated modification patterns and immunity characteristics on tumor-associated cell type in endometrial cancer.
    Yang J; Li J; Li S; Yang Y; Su H; Guo H; Lei J; Wang Y; Wen K; Li X; Zhang S; Wang Z
    Mol Biomed; 2024 Aug; 5(1):32. PubMed ID: 39138733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.
    Liu J; Chen T; Yang M; Zhong Z; Ni S; Yang S; Shao F; Cai L; Bai J; Yu H
    Front Cell Dev Biol; 2021; 9():753004. PubMed ID: 34901000
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer.
    Yang S; Luo Y; Zhou D; Xiang J; Xi X
    Transl Cancer Res; 2023 Oct; 12(10):2556-2571. PubMed ID: 37969377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X; Ye Z; Xiao G; He T
    Comput Biol Med; 2023 Jun; 159():106905. PubMed ID: 37060773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
    Miao C; Fang X; Chen Y; Zhao Y; Guo Q
    Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer.
    Sheng G; Wang T; Gao Y; Wu H; Wu J
    Sci Rep; 2023 Nov; 13(1):19670. PubMed ID: 37952076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.